2001年～2004年7月我院口服降糖药利用分析

目的 :评估我院口服降糖药的应用现状及发展趋势。方法 :对我院2001年～2004年7月口服降糖药的用药频度(DDDs)、销售金额等进行统计、分析。结果 :磺酰脲类药品的DDDs呈下降趋势 ,但其DDDs仍占总DDDs的70 %以上 ,其中格列吡嗪几年来均居DDDs排序第1位 ;双胍类药品的DDDs逐年增高 ;α -葡萄糖苷酶抑制剂和噻唑烷二酮类药品的销售金额呈上升趋势 ;“医保”药品均占总DDDs的97 %以上。结论 :我院口服降糖药的利用基本合理。

Analysis of the Oral Hypoglycemic Agents Used in Our Hospital during the Period of 2001～ July, 2004

OBJECTIVE:To review the current situation and the trend of development of oral hypoglycemic agents in our hospital.METHODS:The defined daily dose DDDs and the sales amount of oral hypoglycemic agents used in our hospital during2001～July,2004were analyzed statistically.RESULTS:The DDDs of sulfonylureas was decreasing,whereas it still accounted for more than70%of the total DDDs;the glipizide ranked the first in DDDs during these years;the DDDs of biguanides kept increasing year by year;the sales amount ofα-glucosidase inhibitor and thiazolidine diketone drugs was inˉcreasing;all the‘Medical Insurance’drugs accounted for more than97%of the total DDDs.CONCLUSION:The oral hyˉpoglycemic agents used in our hospital is rational on the whole.